Kinematics in Posterior Cruciate Retaining and Bi-Cruciate Retaining Total Knee Replacements
NCT ID: NCT03088748
Last Updated: 2021-10-12
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2017-01-31
2020-11-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In Vivo Kinematics for Subjects With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA
NCT04612036
Journey 2 Multi Center Kinematic Study
NCT05107414
Knee Kinematics for Subjects With Zimmer-Biomet Posterior Cruciate Retaining or Posterior Stabilizing Total Knee Arthroplasty
NCT04103515
Analysis of Competitive Posterior Cruciate Retaining (PCR) and Posterior Stabilized (PS) Total Knee Arthroplasty (TKA)
NCT04321356
Optimized Loading Response by JOURNEY II BCS Knee Increases Daily Physical Activity and Functions
NCT02335710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Smith & Nephew Journey II PCR TKA
Subjects implanted with a Smith \& Nephew Journey II posterior cruciate retaining total knee arthroplasty
Journey II posterior cruciate retaining total knee arthroplasty
Smith & Nephew Journey II BCR TKA
Subjects implanted with a Smith \& Nephew Journey II posterior bi-cruciate retaining total knee arthroplasty
Journey II posterior bi-cruciate retaining total knee arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Journey II posterior cruciate retaining total knee arthroplasty
Journey II posterior bi-cruciate retaining total knee arthroplasty
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must be at least three months post-operative
* Must have a Knee Society score of \>90 with no ligamentous laxity or pain
* Weigh 250 pounds or less
* Should have good-to-excellent post-operative flexion
* Must be able to perform activities (without aid of any kind) and without pain, walking up and down a ramp, performing a deep knee bend and rising from that kneeling position after the deep knee bend
* Must not have had other surgical procedures conducted within the past six months that will prohibit them from performing the study activities
* Must have body mass index (BMI) of less than 38
* Must be between 40-85 years of age
* Must be willing to sign the Informed Consent (IC) / HIPAA and PHI Release forms to participate in the study
Exclusion Criteria
* Subjects without the required types of knee implants
* Subjects who are unable to walk up and down a ramp, perform a deep knee bend or rising from that kneeling position without aid or support and without pain
* Subjects who have had other surgical procedures conducted within the past six months that will prohibit them from performing the study activities
40 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Smith & Nephew, Inc.
INDUSTRY
The University of Tennessee, Knoxville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Komistek
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Komistek
Role: PRINCIPAL_INVESTIGATOR
The University of Tennessee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erlanger Health System
Chattanooga, Tennessee, United States
Tennessee Foundation for Education and Research
Knoxville, Tennessee, United States
Tennessee Orthopaedic Clinic
Knoxville, Tennessee, United States
The University of Tennessee
Knoxville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3187FB WIRB20180745
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.